# Neuroimaging Biomarkers of Prognosis in Motor Functional Neurological Disorders

> **NCT03398070** · — · COMPLETED · sponsor: **Massachusetts General Hospital** · enrollment: 30 (actual)

## Conditions studied

- Conversion Disorder

## Interventions

- **OTHER:** Standard of Care

## Key facts

- **NCT ID:** NCT03398070
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-09-01
- **Primary completion:** 2023-01-20
- **Final completion:** 2023-01-20
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2023-08-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03398070

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03398070, "Neuroimaging Biomarkers of Prognosis in Motor Functional Neurological Disorders". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT03398070. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*